Terms: = Bone cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Prognosis
18 results:
1. The Association of Immune Cell Infiltration with Metastasis Location in De Novo Metastatic Triple Negative Breast cancer: A Multicenter Cross-Sectional Study in Indonesia.
Tenggara JB; Rachman A; Prihartono J; Lisnawati L; Panigoro SS; Heriyanto DS; Steven R; Tandarto K; Juanputra S; Sudoyo AW
Acta Med Indones; 2023 Oct; 55(4):376-384. PubMed ID: 38213050
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic value and distribution pattern of tumor infiltrating lymphocytes and their subsets in distant metastases of advanced breast cancer.
Sun XY; Wang CQ; Mao Y; Zhang ZQ; Cui J; Dong XN; Wang HB
Clin Breast Cancer; 2024 Apr; 24(3):e167-e176. PubMed ID: 38212189
[TBL] [Abstract] [Full Text] [Related]
3. E-cadherin expression in the tumor microenvironment of advanced epidermal growth factor receptor-mutant lung adenocarcinoma and the association with prognosis.
Chang YP; Huang GK; Chen YC; Huang KT; Chen YM; Lin CY; Huang CC; Lin MC; Wang CC
BMC Cancer; 2023 Jun; 23(1):569. PubMed ID: 37340370
[TBL] [Abstract] [Full Text] [Related]
4. Tumor Growth Rate in Spinal Giant Cell Tumors of bone and Association With the Immune Microenvironment and Denosumab Treatment Responsiveness: A Multicenter Study.
Zheng BW; Zheng BY; Niu HQ; Yang YF; Zhu GQ; Li J; Zhang TL; Zou MX
Neurosurgery; 2023 Mar; 92(3):524-537. PubMed ID: 36409294
[TBL] [Abstract] [Full Text] [Related]
5. Immune contexture of paediatric cancers.
Thakur MD; Franz CJ; Brennan L; Brouwer-Visser J; Tam R; Korski K; Koeppen H; Ziai J; Babitzki G; Ranchere-Vince D; Vasiljevic A; Dijoud F; Marec-Bérard P; Rochet I; Cannarile MA; Marabelle A
Eur J Cancer; 2022 Jul; 170():179-193. PubMed ID: 35660252
[TBL] [Abstract] [Full Text] [Related]
6. Programmed Death-Ligand 1 Expression and Tumor-Infiltrating Lymphocytes in Temporal bone Squamous Cell Carcinoma.
Hongo T; Kuga R; Miyazaki M; Komune N; Nakano T; Yamamoto H; Koike K; Sato K; Kogo R; Nabeshima K; Oda Y; Nakagawa T
Laryngoscope; 2021 Dec; 131(12):2674-2683. PubMed ID: 34143491
[TBL] [Abstract] [Full Text] [Related]
7. Relative expression and prognostic significance of forkhead box P3 in childhood B-cell acute lymphoblastic leukemia.
Abdelhafeez HEA; Hamid FFA; Hassan NM; Assem MM; Soliman AF
Pediatr Blood Cancer; 2021 Oct; 68(10):e29129. PubMed ID: 34133057
[TBL] [Abstract] [Full Text] [Related]
8. CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.
Fujiwara T; Yakoub MA; Chandler A; Christ AB; Yang G; Ouerfelli O; Rajasekhar VK; Yoshida A; Kondo H; Hata T; Tazawa H; Dogan Y; Moore MAS; Fujiwara T; Ozaki T; Purdue E; Healey JH
Mol Cancer Ther; 2021 Aug; 20(8):1388-1399. PubMed ID: 34088832
[TBL] [Abstract] [Full Text] [Related]
9. Retrospective Analysis of Adoptive TIL Therapy plus Anti-PD1 Therapy in Patients with Chemotherapy-Resistant Metastatic Osteosarcoma.
Zhou X; Wu J; Duan C; Liu Y
J Immunol Res; 2020; 2020():7890985. PubMed ID: 33062726
[TBL] [Abstract] [Full Text] [Related]
10. TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML.
Vadakekolathu J; Lai C; Reeder S; Church SE; Hood T; Lourdusamy A; Rettig MP; Aldoss I; Advani AS; Godwin J; Wieduwilt MJ; Arellano M; Muth J; Yau TO; Ravandi F; Sweet K; Altmann H; Foulds GA; Stölzel F; Middeke JM; Ciciarello M; Curti A; Valk PJM; Löwenberg B; Gojo I; Bornhäuser M; DiPersio JF; Davidson-Moncada JK; Rutella S
Blood Adv; 2020 Oct; 4(20):5011-5024. PubMed ID: 33057635
[TBL] [Abstract] [Full Text] [Related]
11. The Relationship Between Tumor-Stroma Ratio, the Immune Microenvironment, and Survival in Patients With Spinal Chordoma.
Zou MX; Zheng BW; Liu FS; Wang XB; Hu JR; Huang W; Dai ZH; Zhang QS; Liu FB; Zhong H; Jiang Y; She XL; Li XB; Lv GH; Li J
Neurosurgery; 2019 Dec; 85(6):E1095-E1110. PubMed ID: 31501892
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathological implications of TIM3
Zhou J; Jiang Y; Zhang H; Chen L; Luo P; Li L; Zhao J; Lv F; Zou D; Zhang Y; Jing Z
Cancer Immunol Immunother; 2019 Jul; 68(7):1157-1169. PubMed ID: 31197461
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathologic implications of CD8
Zou MX; Guo KM; Lv GH; Huang W; Li J; Wang XB; Jiang Y; She XL
Cancer Immunol Immunother; 2018 Feb; 67(2):209-224. PubMed ID: 29051990
[TBL] [Abstract] [Full Text] [Related]
14. The influence of physical activity in the anti-tumor immune response in experimental breast tumor.
Bianco TM; Abdalla DR; Desidério CS; Thys S; Simoens C; Bogers JP; Murta EFC; Michelin MA
Immunol Lett; 2017 Oct; 190():148-158. PubMed ID: 28818640
[TBL] [Abstract] [Full Text] [Related]
15. Gonadotropin and tumorigenesis: Direct and indirect effects on inflammatory and immunosuppressive mediators and invasion.
Khare P; Bose A; Singh P; Singh S; Javed S; Jain SK; Singh O; Pal R
Mol Carcinog; 2017 Feb; 56(2):359-370. PubMed ID: 27152491
[TBL] [Abstract] [Full Text] [Related]
16. Modulation of bone morphogenic protein signaling in T-cells for cancer immunotherapy.
Kuczma M; Kurczewska A; Kraj P
J Immunotoxicol; 2014 Oct; 11(4):319-27. PubMed ID: 24350726
[TBL] [Abstract] [Full Text] [Related]
17. Association of circulating regulatory T cell number with the incidence and prognosis of diffuse large B-cell lymphoma.
Głowala-Kosińska M; Chwieduk A; Nieckula J; Saduś-Wojciechowska M; Grosicki S; Rusin A; Nowara E; Giebel S
Eur J Haematol; 2013 Aug; 91(2):122-8. PubMed ID: 23679234
[TBL] [Abstract] [Full Text] [Related]
18. Elevated frequencies of CD4⁺ CD25⁺ CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia.
Shenghui Z; Yixiang H; Jianbo W; Kang Y; Laixi B; Yan Z; Xi X
Int J Cancer; 2011 Sep; 129(6):1373-81. PubMed ID: 21105040
[TBL] [Abstract] [Full Text] [Related]
